ERBB2 blocks anoikis in breast cancer cells by downregulating the pro-apoptotic proteins Perp and Bim in a Mek-dependent manner (Reginato et al., 2003; Khan et al., 2016). This evidence concerns the gene MAP2K7 and breast carcinoma.